Covington Capital Management’s Moderna MRNA Stock Holding History

Covington Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$146K	Buy	1,231 +146	+13%	+$22.2K	0.01%	402
2022 Q2	$155K	Buy	1,085 +950	+704%	+$136K	0.01%	399
2022 Q1	$23K	Buy	135 +57	+73%	+$9.6K	﹤0.01%	697
2021 Q4	$20K	Sell	78 -125	-62%	-$36.5K	﹤0.01%	684
2021 Q3	$78K	Sell	203 -604	-75%	-$223K	﹤0.01%	481
2021 Q2	$190K	Buy	807 +582	+259%	+$104K	0.01%	365
2021 Q1	$29K	Buy	225 +25	+13%	+$3.62K	﹤0.01%	548
2020 Q4	$21K	Hold	200	–	–	﹤0.01%	577
2020 Q3	$14K	Buy	200 +100	+100%	+$6.97K	﹤0.01%	599
2020 Q2	$6K	Buy	+100	New	+$5.48K	﹤0.01%	684

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Covington Capital Management's MRNA Position: Q3 2022 in Review

Covington Capital Management increased its Moderna (MRNA) stake by 13% in Q3 2022, buying an estimated $22.2K and bringing the position to 1,231 shares worth $146K. The position accounts for 0.01% of the portfolio, ranked #402.

Covington Capital Management first reported a position in MRNA in Q2 2020 and has held it in 10 quarters since. The position peaked at $190K in Q2 2021. 916 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

Covington Capital Management held 1,231 shares of Moderna worth $146K as of Q3 2022.
Covington Capital Management bought 146 Moderna shares in Q3 2022, an estimated $22.2K.
Moderna made up 0.01% of Covington Capital Management's portfolio in Q3 2022, its #402 holding.
Covington Capital Management first reported a position in Moderna in Q2 2020 and has held it in 10 quarters since.
Covington Capital Management's Moderna position peaked at $190K in Q2 2021.
916 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.